Share this article
Biotech Giant Plans to Securely Share Genetic Data on a Blockchain
A biotech giant based in South Korea is turning to blockchain to allow it to share genetic data without risking patients' privacy.
By Wolfie Zhao
Updated Sep 13, 2021, 8:15 a.m. Published Aug 6, 2018, 1:30 p.m.
A publicly traded biotech giant based in South Korea is turning to blockchain to allow it to share genetic data without risk of hacking or infringement of patients' privacy.
Macrogen, a DNA sequencing service provider with headquarters in Seoul, said in a press release on Monday that it is working with Big Data firm Bigster to develop a blockchain network for the distribution of genomic information, which is slated for completion by June 2019.
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
In the medical field, according to the release, genomic data is used for customized patient diagnosis and treatment, while the pharmaceutical industry can use it for the development of new drugs and therapeutic agents.
Yet, despite the high utilization value of DNA data within healthcare, it is not widely shared due to the sensitive nature of the information to patients and the risk of privacy breaches.
Yang Kap-seok, CEO of Macrogen, commented in the release:
"Despite the fact that genomic data is widely used, it has not been easy to share it because of the problem of personal information protection. With the blockchain platform we seek to build this time, we expect to create an ecosystem that can freely distribute genetic data."
To that end, the firms plan a system based on a consortium blockchain model that will only allow invited parties – such as pharmaceutical firms, research institutes, hospitals and genetic analysis startups – to run as nodes on the decentralized network, limiting who can access the data.
Macrogen is not the only technology giant looking to apply blockchain tech within the genomics industry.
As far back as 2014, an Israeli startup called DNA.Bits announced plans to store genetic and medical record data using blockchain technology.
And, as previously reported by CoinDesk, a patent application filed by Intel indicated that the hardware firm is exploring ways to take advantage of the energy generated during cryptocurrency mining to sequence DNA.
DNA sequence image via Shutterstock
More For You
What to know:
- As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.
- GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.
- Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.
More For You
Coinbase Reopens India Signups, Targets Fiat On-Ramp in 2026 After Two-Year Freeze
Coinbase halted services entirely in 2023, off-boarded millions of Indian users and shuttered local access while reassessing regulatory exposure.
What to know:
- Coinbase has resumed onboarding users in India, marking its return to the market after a two-year hiatus due to regulatory issues.
- The exchange is currently allowing crypto-to-crypto trading and plans to reintroduce fiat on-ramps next year.
- Despite regulatory challenges, Coinbase is investing in India, including increasing its stake in local exchange CoinDCX.
Top Stories
